カテゴリ： 世界, 医療/バイオ, QYResearch

間葉系幹細胞/エクソソーム診断/治療の世界市場2023年：タイプⅠ、タイプⅡ

■ 英語タイトル：Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8822）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8822
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：102
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[間葉系幹細胞/エクソソーム診断/治療の世界市場2023年：タイプⅠ、タイプⅡ]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は間葉系幹細胞/エクソソーム診断/治療のグローバル市場について調査・分析し、世界の間葉系幹細胞/エクソソーム診断/治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（タイプⅠ、タイプⅡ）、用途別セグメント分析（診断、治療、スキンケア）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Tianjin Angsai Cell Genetic Engineering Co. Ltd、Qingdao Aoke Biological Development Co. Ltd、Beijing SH biotechnology Co. Ltd、Beijing Beilai Biotechnology Co. Ltd、Shanghai Aisar Biotechnology Co. Ltd、Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd、Beijing Han's United Biotechnology Co. Ltd、Bosheng Excellence Biotechnology (Beijing) Co. Ltd、Cellular Biomedicine Group、Guangzhou Celera Stem Cell Technology Co. Ltd.、Stem Med Pte Ltd、CryoCord Sdn Bhd、Cytopeutics Sdn Bhd、Stempeutics Research Pvt Ltd、Asian Institute of Gastroenterologyなどが含まれています。間葉系幹細胞/エクソソーム診断/治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、間葉系幹細胞/エクソソーム診断/治療市場規模を算出する際に考慮しました。

・間葉系幹細胞/エクソソーム診断/治療市場の概要
- 間葉系幹細胞/エクソソーム診断/治療の種類別セグメント
- 世界の間葉系幹細胞/エクソソーム診断/治療市場規模：タイプ別分析（タイプⅠ、タイプⅡ）
- 間葉系幹細胞/エクソソーム診断/治療の用途別セグメント
- 世界の間葉系幹細胞/エクソソーム診断/治療市場規模：用途別分析（診断、治療、スキンケア）
- 世界の間葉系幹細胞/エクソソーム診断/治療市場規模予測（2018年-2029年）

・間葉系幹細胞/エクソソーム診断/治療市場の成長トレンド
- 間葉系幹細胞/エクソソーム診断/治療の地域別市場規模（2018年-2029年）
- 間葉系幹細胞/エクソソーム診断/治療市場ダイナミクス
- 間葉系幹細胞/エクソソーム診断/治療の業界動向
- 間葉系幹細胞/エクソソーム診断/治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：タイプⅠ、タイプⅡ
- 世界の間葉系幹細胞/エクソソーム診断/治療のタイプ別市場規模（2018年-2023年）
- 世界の間葉系幹細胞/エクソソーム診断/治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：診断、治療、スキンケア
- 世界の間葉系幹細胞/エクソソーム診断/治療の用途別市場規模（2018年-2023年）
- 世界の間葉系幹細胞/エクソソーム診断/治療の用途別市場規模（2024年-2029年）

・間葉系幹細胞/エクソソーム診断/治療の地域別市場規模
- 北米の間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年）
- 米国の間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年）
- ヨーロッパの間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年）
- アジア太平洋の間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年）
- 中国の間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年）
- 日本の間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年）
- 韓国の間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年）
- インドの間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年）
- オーストラリアの間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年）
- 中南米の間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年）
- 中東・アフリカの間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Tianjin Angsai Cell Genetic Engineering Co. Ltd、Qingdao Aoke Biological Development Co. Ltd、Beijing SH biotechnology Co. Ltd、Beijing Beilai Biotechnology Co. Ltd、Shanghai Aisar Biotechnology Co. Ltd、Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd、Beijing Han's United Biotechnology Co. Ltd、Bosheng Excellence Biotechnology (Beijing) Co. Ltd、Cellular Biomedicine Group、Guangzhou Celera Stem Cell Technology Co. Ltd.、Stem Med Pte Ltd、CryoCord Sdn Bhd、Cytopeutics Sdn Bhd、Stempeutics Research Pvt Ltd、Asian Institute of Gastroenterology

・アナリストの観点/結論

・調査手法と情報源

Exosomes are a type of vesicles (Extracellular Vesicles, EVs) secreted by cells to the outside of the cell, with a size of 30-150nm, a double-layer membrane structure and a saucer-like shape, and rich contents (including nucleic acids, proteins and lipids, etc.), involved in the transfer of molecules between cells.
As an emerging technology, it has many problems, including accurately encoding and delivering targeted therapeutics, not to mention issues surrounding intellectual property and large-scale manufacturing. For diagnostic applications, products from Exosome Diagnostics are available; for therapeutic applications, although there are three listed companies focusing on exosomes – Capricor, Puretech and Reneuron, none of the company’s products have actually been used in clinical practice.
Highlights
The global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Exosome industry in China is in the initial stage of germination and development, The exosome industry in foreign currently has a limited number of players. Geographically speaking, China holds about 80% of total market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Msenchymal Stem Cell and Exosome Diagnostics and Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Msenchymal Stem Cell and Exosome Diagnostics and Therapies.
The Msenchymal Stem Cell and Exosome Diagnostics and Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Msenchymal Stem Cell and Exosome Diagnostics and Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Tianjin Angsai Cell Genetic Engineering Co. Ltd
Qingdao Aoke Biological Development Co. Ltd
Beijing SH biotechnology Co. Ltd
Beijing Beilai Biotechnology Co. Ltd
Shanghai Aisar Biotechnology Co. Ltd
Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
Beijing Han’s United Biotechnology Co. Ltd
Bosheng Excellence Biotechnology (Beijing) Co. Ltd
Cellular Biomedicine Group
Guangzhou Celera Stem Cell Technology Co. Ltd.
Stem Med Pte Ltd
CryoCord Sdn Bhd
Cytopeutics Sdn Bhd
Stempeutics Research Pvt Ltd
Asian Institute of Gastroenterology
Segment by Type
Type I
Type II
Segment by Application
Diagnostics
Therapies
Skincare
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Msenchymal Stem Cell and Exosome Diagnostics and Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Type I
1.2.3 Type II
1.3 Market by Application
1.3.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diagnostics
1.3.3 Therapies
1.3.4 Skincare
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Perspective (2018-2029)
2.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Growth Trends by Region
2.2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Historic Market Size by Region (2018-2023)
2.2.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Region (2024-2029)
2.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Dynamics
2.3.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Trends
2.3.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Drivers
2.3.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Challenges
2.3.4 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Revenue
3.1.1 Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Revenue (2018-2023)
3.1.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Players (2018-2023)
3.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue
3.4 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Concentration Ratio
3.4.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in 2022
3.5 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Key Players Head office and Area Served
3.6 Key Players Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Solution and Service
3.7 Date of Enter into Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Breakdown Data by Type
4.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Historic Market Size by Type (2018-2023)
4.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Type (2024-2029)
5 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Breakdown Data by Application
5.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Historic Market Size by Application (2018-2023)
5.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2018-2029)
6.2 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2018-2023)
6.4 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2018-2029)
7.2 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2018-2023)
7.4 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2018-2029)
8.2 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2018-2023)
8.4 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2018-2029)
9.2 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2018-2023)
9.4 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2018-2029)
10.2 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2018-2023)
10.4 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Tianjin Angsai Cell Genetic Engineering Co. Ltd
11.1.1 Tianjin Angsai Cell Genetic Engineering Co. Ltd Company Detail
11.1.2 Tianjin Angsai Cell Genetic Engineering Co. Ltd Business Overview
11.1.3 Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.1.4 Tianjin Angsai Cell Genetic Engineering Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.1.5 Tianjin Angsai Cell Genetic Engineering Co. Ltd Recent Development
11.2 Qingdao Aoke Biological Development Co. Ltd
11.2.1 Qingdao Aoke Biological Development Co. Ltd Company Detail
11.2.2 Qingdao Aoke Biological Development Co. Ltd Business Overview
11.2.3 Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.2.4 Qingdao Aoke Biological Development Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.2.5 Qingdao Aoke Biological Development Co. Ltd Recent Development
11.3 Beijing SH biotechnology Co. Ltd
11.3.1 Beijing SH biotechnology Co. Ltd Company Detail
11.3.2 Beijing SH biotechnology Co. Ltd Business Overview
11.3.3 Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.3.4 Beijing SH biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.3.5 Beijing SH biotechnology Co. Ltd Recent Development
11.4 Beijing Beilai Biotechnology Co. Ltd
11.4.1 Beijing Beilai Biotechnology Co. Ltd Company Detail
11.4.2 Beijing Beilai Biotechnology Co. Ltd Business Overview
11.4.3 Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.4.4 Beijing Beilai Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.4.5 Beijing Beilai Biotechnology Co. Ltd Recent Development
11.5 Shanghai Aisar Biotechnology Co. Ltd
11.5.1 Shanghai Aisar Biotechnology Co. Ltd Company Detail
11.5.2 Shanghai Aisar Biotechnology Co. Ltd Business Overview
11.5.3 Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.5.4 Shanghai Aisar Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.5.5 Shanghai Aisar Biotechnology Co. Ltd Recent Development
11.6 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
11.6.1 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Company Detail
11.6.2 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Business Overview
11.6.3 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.6.4 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.6.5 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Recent Development
11.7 Beijing Han’s United Biotechnology Co. Ltd
11.7.1 Beijing Han’s United Biotechnology Co. Ltd Company Detail
11.7.2 Beijing Han’s United Biotechnology Co. Ltd Business Overview
11.7.3 Beijing Han’s United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.7.4 Beijing Han’s United Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.7.5 Beijing Han’s United Biotechnology Co. Ltd Recent Development
11.8 Bosheng Excellence Biotechnology (Beijing) Co. Ltd
11.8.1 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Company Detail
11.8.2 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Business Overview
11.8.3 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.8.4 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.8.5 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Recent Development
11.9 Cellular Biomedicine Group
11.9.1 Cellular Biomedicine Group Company Detail
11.9.2 Cellular Biomedicine Group Business Overview
11.9.3 Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.9.4 Cellular Biomedicine Group Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.9.5 Cellular Biomedicine Group Recent Development
11.10 Guangzhou Celera Stem Cell Technology Co. Ltd.
11.10.1 Guangzhou Celera Stem Cell Technology Co. Ltd. Company Detail
11.10.2 Guangzhou Celera Stem Cell Technology Co. Ltd. Business Overview
11.10.3 Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.10.4 Guangzhou Celera Stem Cell Technology Co. Ltd. Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.10.5 Guangzhou Celera Stem Cell Technology Co. Ltd. Recent Development
11.11 Stem Med Pte Ltd
11.11.1 Stem Med Pte Ltd Company Detail
11.11.2 Stem Med Pte Ltd Business Overview
11.11.3 Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.11.4 Stem Med Pte Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.11.5 Stem Med Pte Ltd Recent Development
11.12 CryoCord Sdn Bhd
11.12.1 CryoCord Sdn Bhd Company Detail
11.12.2 CryoCord Sdn Bhd Business Overview
11.12.3 CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.12.4 CryoCord Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.12.5 CryoCord Sdn Bhd Recent Development
11.13 Cytopeutics Sdn Bhd
11.13.1 Cytopeutics Sdn Bhd Company Detail
11.13.2 Cytopeutics Sdn Bhd Business Overview
11.13.3 Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.13.4 Cytopeutics Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.13.5 Cytopeutics Sdn Bhd Recent Development
11.14 Stempeutics Research Pvt Ltd
11.14.1 Stempeutics Research Pvt Ltd Company Detail
11.14.2 Stempeutics Research Pvt Ltd Business Overview
11.14.3 Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.14.4 Stempeutics Research Pvt Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.14.5 Stempeutics Research Pvt Ltd Recent Development
11.15 Asian Institute of Gastroenterology
11.15.1 Asian Institute of Gastroenterology Company Detail
11.15.2 Asian Institute of Gastroenterology Business Overview
11.15.3 Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.15.4 Asian Institute of Gastroenterology Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.15.5 Asian Institute of Gastroenterology Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Type I
Table 3. Key Players of Type II
Table 4. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Region (2018-2023)
Table 8. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Region (2024-2029)
Table 10. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Trends
Table 11. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Drivers
Table 12. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Challenges
Table 13. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Restraints
Table 14. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Players (2018-2023)
Table 16. Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies as of 2022)
Table 17. Ranking of Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Solution and Service
Table 21. Date of Enter into Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Type (2018-2023)
Table 25. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Type (2024-2029)
Table 27. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Application (2018-2023)
Table 29. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Application (2024-2029)
Table 31. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2024-2029) & (US$ Million)
Table 46. Tianjin Angsai Cell Genetic Engineering Co. Ltd Company Detail
Table 47. Tianjin Angsai Cell Genetic Engineering Co. Ltd Business Overview
Table 48. Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product
Table 49. Tianjin Angsai Cell Genetic Engineering Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023) & (US$ Million)
Table 50. Tianjin Angsai Cell Genetic Engineering Co. Ltd Recent Development
Table 51. Qingdao Aoke Biological Development Co. Ltd Company Detail
Table 52. Qingdao Aoke Biological Development Co. Ltd Business Overview
Table 53. Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product
Table 54. Qingdao Aoke Biological Development Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023) & (US$ Million)
Table 55. Qingdao Aoke Biological Development Co. Ltd Recent Development
Table 56. Beijing SH biotechnology Co. Ltd Company Detail
Table 57. Beijing SH biotechnology Co. Ltd Business Overview
Table 58. Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product
Table 59. Beijing SH biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023) & (US$ Million)
Table 60. Beijing SH biotechnology Co. Ltd Recent Development
Table 61. Beijing Beilai Biotechnology Co. Ltd Company Detail
Table 62. Beijing Beilai Biotechnology Co. Ltd Business Overview
Table 63. Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product
Table 64. Beijing Beilai Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023) & (US$ Million)
Table 65. Beijing Beilai Biotechnology Co. Ltd Recent Development
Table 66. Shanghai Aisar Biotechnology Co. Ltd Company Detail
Table 67. Shanghai Aisar Biotechnology Co. Ltd Business Overview
Table 68. Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product
Table 69. Shanghai Aisar Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023) & (US$ Million)
Table 70. Shanghai Aisar Biotechnology Co. Ltd Recent Development
Table 71. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Company Detail
Table 72. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Business Overview
Table 73. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product
Table 74. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023) & (US$ Million)
Table 75. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Recent Development
Table 76. Beijing Han's United Biotechnology Co. Ltd Company Detail
Table 77. Beijing Han's United Biotechnology Co. Ltd Business Overview
Table 78. Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product
Table 79. Beijing Han's United Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023) & (US$ Million)
Table 80. Beijing Han's United Biotechnology Co. Ltd Recent Development
Table 81. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Company Detail
Table 82. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Business Overview
Table 83. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product
Table 84. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023) & (US$ Million)
Table 85. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Recent Development
Table 86. Cellular Biomedicine Group Company Detail
Table 87. Cellular Biomedicine Group Business Overview
Table 88. Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product
Table 89. Cellular Biomedicine Group Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023) & (US$ Million)
Table 90. Cellular Biomedicine Group Recent Development
Table 91. Guangzhou Celera Stem Cell Technology Co. Ltd. Company Detail
Table 92. Guangzhou Celera Stem Cell Technology Co. Ltd. Business Overview
Table 93. Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product
Table 94. Guangzhou Celera Stem Cell Technology Co. Ltd. Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023) & (US$ Million)
Table 95. Guangzhou Celera Stem Cell Technology Co. Ltd. Recent Development
Table 96. Stem Med Pte Ltd Company Detail
Table 97. Stem Med Pte Ltd Business Overview
Table 98. Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product
Table 99. Stem Med Pte Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023) & (US$ Million)
Table 100. Stem Med Pte Ltd Recent Development
Table 101. CryoCord Sdn Bhd Company Detail
Table 102. CryoCord Sdn Bhd Business Overview
Table 103. CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product
Table 104. CryoCord Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023) & (US$ Million)
Table 105. CryoCord Sdn Bhd Recent Development
Table 106. Cytopeutics Sdn Bhd Company Detail
Table 107. Cytopeutics Sdn Bhd Business Overview
Table 108. Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product
Table 109. Cytopeutics Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023) & (US$ Million)
Table 110. Cytopeutics Sdn Bhd Recent Development
Table 111. Stempeutics Research Pvt Ltd Company Detail
Table 112. Stempeutics Research Pvt Ltd Business Overview
Table 113. Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product
Table 114. Stempeutics Research Pvt Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023) & (US$ Million)
Table 115. Stempeutics Research Pvt Ltd Recent Development
Table 116. Asian Institute of Gastroenterology Company Detail
Table 117. Asian Institute of Gastroenterology Business Overview
Table 118. Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product
Table 119. Asian Institute of Gastroenterology Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023) & (US$ Million)
Table 120. Asian Institute of Gastroenterology Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Type: 2022 VS 2029
Figure 3. Type I Features
Figure 4. Type II Features
Figure 5. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Application: 2022 VS 2029
Figure 7. Diagnostics Case Studies
Figure 8. Therapies Case Studies
Figure 9. Skincare Case Studies
Figure 10. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Report Years Considered
Figure 11. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Region: 2022 VS 2029
Figure 14. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Players in 2022
Figure 15. Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in 2022
Figure 17. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2018-2029)
Figure 19. United States Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2018-2029)
Figure 23. Germany Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Region (2018-2029)
Figure 31. China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2018-2029)
Figure 39. Mexico Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2018-2029)
Figure 43. Turkey Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Tianjin Angsai Cell Genetic Engineering Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
Figure 46. Qingdao Aoke Biological Development Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
Figure 47. Beijing SH biotechnology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
Figure 48. Beijing Beilai Biotechnology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
Figure 49. Shanghai Aisar Biotechnology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
Figure 50. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
Figure 51. Beijing Han's United Biotechnology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
Figure 52. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
Figure 53. Cellular Biomedicine Group Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
Figure 54. Guangzhou Celera Stem Cell Technology Co. Ltd. Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
Figure 55. Stem Med Pte Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
Figure 56. CryoCord Sdn Bhd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
Figure 57. Cytopeutics Sdn Bhd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
Figure 58. Stempeutics Research Pvt Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
Figure 59. Asian Institute of Gastroenterology Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • P-アミノベンゾニトリルのグローバル市場展望 2023年-2029年：タイプI、タイプII
  • 呼吸器ボプシーキットのグローバル市場展望 2023年-2029年：タイプI、タイプII
  • サソンシードガムのグローバル市場展望 2023年-2029年：タイプI、タイプII
  • ハント石のグローバル市場展望 2023年-2029年：タイプI、タイプII
  • 電界強度計のグローバル市場展望 2023年-2029年：タイプI、タイプII
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8822 )"間葉系幹細胞/エクソソーム診断/治療の世界市場2023年：タイプⅠ、タイプⅡ" (英文：Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。